These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 9774249
1. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits. Brunvand H, Liu G, Ma XL, Yue TL, Ruffolo RR, Feuerstein GZ. Eur J Pharmacol; 1998 Sep 04; 356(2-3):193-8. PubMed ID: 9774249 [Abstract] [Full Text] [Related]
2. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR, Ma XL. Eur J Pharmacol; 1998 Jun 26; 351(3):341-50. PubMed ID: 9721026 [Abstract] [Full Text] [Related]
3. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat. Smith EF, Griswold DE, Hillegass LM, Slivjak MJ, Davis PA, DiMartino MJ. Pharmacology; 1992 Jun 26; 44(6):297-305. PubMed ID: 1354874 [Abstract] [Full Text] [Related]
4. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF. Cardiovasc Res; 1992 May 26; 26(5):518-25. PubMed ID: 1359930 [Abstract] [Full Text] [Related]
5. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR, Ohlstein EH, Ma XL, Yue TL. Eur J Pharmacol; 2000 Oct 06; 406(1):109-16. PubMed ID: 11011041 [Abstract] [Full Text] [Related]
6. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. Brunvand H, Frłyland L, Hexeberg E, Rynning SE, Berge RK, Grong K. Eur J Pharmacol; 1996 Oct 24; 314(1-2):99-107. PubMed ID: 8957224 [Abstract] [Full Text] [Related]
7. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, Gu JL, Kumar S, Poste G, Ruffolo RR, Feuerstein GZ. Circ Res; 1998 Feb 09; 82(2):166-74. PubMed ID: 9468187 [Abstract] [Full Text] [Related]
8. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. Ma XL, Yue TL, Lopez BL, Barone FC, Christopher TA, Ruffolo RR, Feuerstein GZ. J Pharmacol Exp Ther; 1996 Apr 09; 277(1):128-36. PubMed ID: 8613909 [Abstract] [Full Text] [Related]
9. Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury. Christopher TA, Lopez BL, Ma XL, Feuerstein GZ, Ruffolo RR, Yue TL. Br J Pharmacol; 1998 Jan 09; 123(2):292-8. PubMed ID: 9489618 [Abstract] [Full Text] [Related]
13. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts. Kramer JH, Weglicki WB. Free Radic Biol Med; 1996 Jan 09; 21(6):813-25. PubMed ID: 8902527 [Abstract] [Full Text] [Related]
14. Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. Cargnoni A, Ceconi C, Bernocchi P, Boraso A, Parrinello G, Curello S, Ferrari R. Cardiovasc Res; 2000 Aug 18; 47(3):556-66. PubMed ID: 10963728 [Abstract] [Full Text] [Related]
20. Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion. Zhao J, Yang Y, you S, Cui C, Gao R. Int J Cardiol; 2007 Feb 14; 115(3):334-41. PubMed ID: 16824628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]